FDA Clearance Tracker · K232737
PowerPort ClearVUE Slim ECG Enabled Implantable Port; PowerPort ClearVUE isp ECG Enabled Implantable Port; PowerPort isp M.R.I. ECG Enabled Implantable Port; PowerPort Slim ECG Enabled Implantable Port
Last checked: Nov 20, 2026Latest source record: Dec 8, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Dec 8, 2023
Substantially Equivalent
Time to decision
92 days
Received Sep 7, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K232737
- Device name
- PowerPort ClearVUE Slim ECG Enabled Implantable Port; PowerPort ClearVUE isp ECG Enabled Implantable Port; PowerPort isp M.R.I. ECG Enabled Implantable Port; PowerPort Slim ECG Enabled Implantable Port
- Applicant
- Bard Peripheral Vascular, Inc.
- Applicant location
- Tempe, AZ
- Received
- Sep 7, 2023
- Decided
- Dec 8, 2023
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 880.5965
- Specialty
- Hospital Medicine & Nursing
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LJT. The earliest in FDA's data is K823838, decided Jan 12, 1983.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K232737
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Bard Peripheral Vascular, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P250050 · Decided Sep 25, 2026 · 303 days after receipt
Device type: SHUNT, PORTOSYSTEMIC, ENDOPROSTHESIS (MIR) · Cardiology
K262571 · Decided Aug 14, 2026 · 21 days after receipt
Device type: Instrument, Biopsy (KNW) · GI, Urology & Nephrology
K260012 · Decided Feb 4, 2026 · 30 days after receipt
Device type: Catheter, Percutaneous, Cutting/Scoring (PNO) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.